About Sera Prognostics, Inc. 
Sera Prognostics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 20 Schemes (16.43%)
Foreign Institutions
Held by 24 Foreign Institutions (3.12%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-8 Million
Pharmaceuticals & Biotechnology
USD 121 Million ()
NA (Loss Making)
NA
0.00%
-0.45
-37.10%
1.37






